STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G] C3is Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary

C3is Inc. Schedule 13G shows Wexford-affiliated reporting persons jointly hold 110,382 shares of C3is common stock, representing 10.23% of the 1,079,208 shares outstanding used for the calculation. The holdings are reported as shared voting and dispositive power with no sole voting or dispositive power. The filing attributes ownership to certain Wexford funds and explains that Wexford Capital LP, Wexford GP LLC, Charles E. Davidson and Joseph M. Jacobs share the power to vote and dispose of the shares, while disclaiming beneficial ownership except to the extent of pecuniary interest for Davidson and Jacobs. The percentage is based on the issuer's Form F-1 reported share count as of August 31, 2025, and the ownership position is stated as of September 22, 2025.

Positive
  • Material disclosure of a >10% position provides transparency to the market
  • Joint Filing Agreement and detailed attribution clarify relationships among reporting persons
Negative
  • Concentration risk: a single affiliated group holds 10.23% of outstanding shares
  • Shared voting power indicates potential coordination that some investors may view as governance risk

Insights

TL;DR: Wexford group disclosed a >10% passive stake with shared control via funds.

The Schedule 13G indicates the Wexford reporting persons collectively may be deemed to beneficially own 110,382 shares or 10.23% of C3is based on the registrant's F-1 share count. The position is reported under shared voting and dispositive power, consistent with holdings held by affiliated funds rather than direct sole ownership. The filing includes a disclaimer of beneficial ownership by the entities except for pecuniary interests of two individuals, which is common for fund-structured holdings. For investors, this is a material passive stake disclosure but not an active control assertion.

TL;DR: Disclosure shows group coordination and joint filing, not necessarily a control intent.

The document cites a Joint Filing Agreement and describes the relationships among Wexford Capital, its GP and two principals, explaining why the reporting persons filed jointly. The shared voting and dispositive powers reflect fund-level arrangements; the certification affirms the stake was not acquired to influence control. This filing clarifies governance signaling: material ownership disclosed but accompanied by explicit disclaimers to limit control implications.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: Ownership as of September 22, 2025. See Item 4(b) for additional details.


SCHEDULE 13G




Comment for Type of Reporting Person: Ownership as of September 22, 2025. See Item 4(b) for additional details.


SCHEDULE 13G




Comment for Type of Reporting Person: Ownership as of September 22, 2025. See Item 4(b) for additional details.


SCHEDULE 13G




Comment for Type of Reporting Person: Ownership as of September 22, 2025. See Item 4(b) for additional details.


SCHEDULE 13G



WEXFORD CAPITAL LP
Signature:/s/ Mark E. Ahern
Name/Title:By: Wexford GP LLC, its General Partner, By: Mark E. Ahern, Vice President and Assistant Secretary
Date:09/24/2025
Wexford GP LLC
Signature:/s/ Mark E. Ahern
Name/Title:Wexford GP LLC, By: Mark E. Ahern, Vice President and Assistant Secretary
Date:09/24/2025
Charles Davidson
Signature:/s/ Charles E. Davidson
Name/Title:Charles E. Davidson
Date:09/24/2025
Joseph Jacobs
Signature:/s/ Joseph M. Jacobs
Name/Title:Joseph M. Jacobs
Date:09/24/2025

FAQ

What stake does Wexford report in CISS?

The filing reports 110,382 shares, equal to 10.23% of C3is common stock based on 1,079,208 shares outstanding used for the calculation.

Who are the reporting persons on the Schedule 13G for CISS?

The reporting persons are Wexford Capital LP, Wexford GP LLC, Charles E. Davidson and Joseph M. Jacobs.

Does the filing indicate sole voting or dispositive power for the reporting persons?

No; the filing reports 0 shares with sole voting or dispositive power and 110,382 shares with shared voting and dispositive power.

As of what date is the ownership reported?

Ownership is reported as of September 22, 2025, with the share count for percentage calculation as of August 31, 2025 from the issuer's Form F-1.

Was the stake disclosed as intended to influence control of C3is (CISS)?

The certification states the securities were not acquired to change or influence control of the issuer, consistent with a Schedule 13G passive disclosure.
C3is

NASDAQ:CISS

CISS Rankings

CISS Latest News

CISS Latest SEC Filings

CISS Stock Data

4.81M
2.29M
22.93%
5.09%
10.56%
Marine Shipping
Industrials
Link
Greece
Athens